Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual Market Access Oncology Forum

16 Oct 2012 - 17 Oct 2012 - Barcelona, Spain



Bookmark and Share


Fleming Europe is proud to organise its 2nd Annual Market Access Oncology Forum. On 16 – 17 October 2012 it is coming to Barcelona, Spain.

Invited expert speakers from pharma companies such as Celgene, Merck Serono, Amgen, J&J and non-industry speakers from INFARMED, HAS – SANTE, The World Bank, OECD and European Cancer Patient Coalition, will bring their valuable insights into the health care policy developments where the oncology market is maturing and access is increasingly restricted.

By joining us the attendees will learn how to:

- Create a strong value story to enhance the willingness to pay

- Customise your market access strategy

- Redefine the clinical trial process in order to meet the future demand for Value Based Medicine

- Optimally communicate value to all stakeholders

- Explore the concept of risk-sharing

- Benefit from the presence of HTA’s and maximise your chances at regulatory approval

For the event details, please request the event brochure http://pharma.flemingeurope.com/oncology-market-access/request-agenda



Further information
Scientific News
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Symmetry is Key to Collagen
Researchers describe how symmetry may be the key to growing collagen fibres outside the body.
Lose Weight, Escape the Eight: Weight-Based Cancer Risk
IARC has identified eight additional cancer sites linked to overweight and obesity.
Unravelling the Metastatic Mechanism of Melanoma
Research has uncovered the mechanism of melanoma spreading; the findings could lead to a cure for the disease.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!